Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
GI Eosinophilic Disorders
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
Answer from: at Community Practice
I would do the higher dose (EoE) if starting it for both.
Sign in or Register to read more
23638
Related Questions
How often do you find a food allergy on a skin test in an EoE patient that when avoided will result in significant resolution of EoE?
What patients with food allergies do you screen for EoE?
Is there a role for anti-IL5 therapy in the treatment of EoE?
If you have a patient with EoE on Dupixent 300 mg weekly, and they have severe tree nut allergies, would it be safe to add Xolair for severe food allergy?
Is there a role for use of dupilumab for hypereosinophilic GI disorders distal to the esophagus?
Can a biopsy finding of eosinophilia in the gut (esophagus, stomach, duodenum) be reactive in the setting of Crohn's disease or due to anti-TNF blockade?
What is your approach to biologic selection in a patient with resistant/persistent ABPA?
In those patients who are initiated on omalizumab for multiple food allergies, once baked egg and baked milk are introduced into the diet, do you rely upon skin prick testing and/or ImmunoCAP testing in order to make the decision to introduce prepared egg or whole milk into the diet?
What factors do you consider prior to offering a trial of ICS/LABA therapy versus a methacholine challenge test in patients with suspected asthma but normal pulmonary function testing?
What are the implications of checking post-vaccine titers after administration of Prevnar 20 compared to PPSV23?